Yahoo Finance

FDA Approves Medtronic's Recharge-Free Sacral Nerve Stimulation Therapy For Bladder, Bowel Control

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
MD&M East

Medtronic Scores FDA Nod for Next-Gen InterStim

Medtronic continues to up its game in sacral neuromodulation. FDA approved InterStim X, the next generation of the company's InterStim portfolio's recharge-free device. Medtronic said implants have ...
BioWorld

Stimguard set to study its tibial nerve OAB system against Medtronic's Interstim device

Stimguard LLC will begin enrollment for a head-to-head study of its Chronic Affarent Nerve Stimulator (CAN-stim) against Medtronic plc's gold standard Interstim device in treatment of urgency urinary ...
Yahoo Finance

Five-Year Data Demonstrate InterStim(TM) Therapy Offers Sustained Long-Term Efficacy and Quality of Life Improvements for Overactive Bladder Patients

DUBLIN - July 17, 2017 - Medtronic plc (MDT) today announced that the InterStim(TM) system, which provides sacral neuromodulation therapy, offers sustained long-term efficacy and quality of life ...
Nasdaq

Medtronic Announces FDA Submission for InterStim™ Micro Neurostimulator and SureScan™ MRI Leads

Smaller, Rechargeable Device Will Provide More Choices for Patients Suffering with Bladder and Bowel Control Issues SureScan™ MRI Leads Will Provide Full-Body MRI Conditional Labeling The rechargeable ...
health.economictimes.indiatimes

Medtronic launches FDA approved InterStim X sacral nerve stimulation therapy for bladder control, bowel control in India

Sacral neuromodulation is an advanced therapy for people with bladder and bowel control issues that are not responding to other non-invasive therapies. The system works by targeting nerve signals that ...
Medscape

Overactive Bladder: Drug Therapy Versus Nerve Stimulation

Nat Clin Pract Urol. 2005;2(7):310-311. The InterStim® device has greatly increased the number of candidates for surgical therapy. This therapy involves an initial percutaneous nerve evaluation to ...
Monthly Prescribing Reference

Study Compares OnabotulinumtoxinA to InterStim for Female Urinary Incontinence

(HealthDay News) — For women with refractory urgency urinary incontinence, onabotulinumtoxinA injections may help control leakage better than the implanted nerve stimulation device InterStim, ...
Star Tribune

Medtronic ratchets up patent spat for device that aids in bladder, bowel control

Medtronic is upping the ante in a patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic’s InterStim device, an implanted ...
Nasdaq

Medtronic (MDT) Progresses in SNM With Updated InterStim Label

Medtronic’s MDT neuromodulation business advanced recently with the company receiving FDA’s expanded MRI labeling approval for its InterStim line of sacral neuromodulation (SNM) systems. The updated ...
WNDU

Medical Moment: Interstim, a new device to help deal with incontinence

Add Us On GoogleAdd as a preferred source on Google (WNDU) - It’s a taboo topic that nobody talks about. But 1 in 6 Americans suffer with either urinary or bowel incontinence. That’s more than the ...